Hypothalamic-pituitary-thyroid-axis function in treatment resistant depression

被引:30
作者
Vandoolaeghe, E
Maes, M
Vandevyvere, J
Neels, H
机构
[1] UNIV ANTWERP, AZ STUIVENBERG, DEPT PSYCHIAT, B-2020 ANTWERP, BELGIUM
[2] VANDERBILT UNIV, DEPT PSYCHIAT, NASHVILLE, TN USA
[3] AZ MIDDELHEIM, DEPT NUCL MED, ANTWERP, BELGIUM
[4] OCMW HOSP, LAB CLIN BIOL, ANTWERP, BELGIUM
关键词
treatment resistant major depression; thyroid hormones; thyroid-stimulating hormone; thyroxine;
D O I
10.1016/S0165-0327(96)01426-7
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Recently, there were some reports that the prevalence of various grades of hypothyroidism may be increased in patients with treatment resistant depression (TRD). The aim of the present study was to examine serum basal thyroid-stimulating hormone (TSH) and thyroxine (T4) levels in 36 major depressed subjects, of whom 27 had TRD and 15 were normal volunteers. There were no significant differences in serum basal TSH or T4 levels between major depressed subjects and normal controls, or between patients with TRD versus normal controls or subjects without TRD. There was a trend towards lower serum basal T4 concentrations in patients with TRD than in other depressed patients and normal controls. One patient with TRD had basal serum TSH levels in the hyperthyroid range. Two subjects, one with TRD and one normal control, had serum TSH values in the subclinical hypothyroid zone, but their serum T4 values were in the euthyroid range. There were no significant relationships between basal TSH or T4 and severity of illness, staging of depression based on prior treatment non-response, length of the depressive episode, duration of illness, or number of previous depressive episodes. In conclusion, the results of this study do not provide evidence that (subclinical) hypothyroidism occurs more than coincidentally in depressed patients with TRD. (C) 1997 Elsevier Science B.V.
引用
收藏
页码:143 / 150
页数:8
相关论文
共 44 条
[1]   TRH stimulation test as a predictor of acute and long-term antidepressant response in major depression [J].
Amsterdam, JD ;
Fava, M ;
Maislin, G ;
Rosenbaum, J ;
HornigRohan, M .
JOURNAL OF AFFECTIVE DISORDERS, 1996, 38 (2-3) :165-172
[2]   FLUOXETINE EFFICACY IN TREATMENT-RESISTANT DEPRESSION [J].
AMSTERDAM, JD ;
MAISLIN, G ;
POTTER, L .
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 1994, 18 (02) :243-261
[3]  
[Anonymous], 1987, DIAGNOSTIC STAT MANU, V4th
[4]   METABOLIC IMPLICATIONS OF LOW-DOSE TRIIODOTHYRONINE ADMINISTRATION IN RATS - RELEVANCE TO THE ADJUNCTIVE USE OF TRIIODOTHYRONINE IN THE TREATMENT OF DEPRESSION [J].
BARSANO, CP ;
GARCES, J ;
IQBAL, Z .
BIOLOGICAL PSYCHIATRY, 1994, 35 (10) :814-823
[5]  
BAUER MS, 1990, ARCH GEN PSYCHIAT, V47, P427
[6]  
BOTTGER IG, 1987, THYROTROPIN ULTRASEN, P219
[7]   THE THYROID AXIS AND DESIPRAMINE TREATMENT IN DEPRESSION [J].
BRADY, KT ;
ANTON, RF .
BIOLOGICAL PSYCHIATRY, 1989, 25 (06) :703-709
[8]   ENDOCRINE CHANGES AND CLINICAL PROFILES IN DEPRESSION .2. THE THYROTROPIN-RELEASING-HORMONE TEST [J].
CALLOWAY, SP ;
DOLAN, RJ ;
FONAGY, P ;
DESOUZA, VFA ;
WAKELING, A .
PSYCHOLOGICAL MEDICINE, 1984, 14 (04) :759-765
[9]  
COWDRY RW, 1983, ARCH GEN PSYCHIAT, V40, P414
[10]   TREATMENT APPROACHES TO THERAPY-RESISTANT DEPRESSION [J].
DINAN, T .
JOURNAL OF PSYCHOPHARMACOLOGY, 1995, 9 (02) :199-204